InvestorsHub Logo
Followers 4
Posts 702
Boards Moderated 0
Alias Born 05/19/2016

Re: None

Tuesday, 12/13/2016 9:31:56 PM

Tuesday, December 13, 2016 9:31:56 PM

Post# of 462905
Why the delay getting Rett Syndrome trial started??

Perhaps it is carefully thought out to maximize profits for shareholders. If 2-73 had started Rett trials this year it would probably have been approved right around now. That means that the 7 years of patent protection for 2-73 as an orphan drug would start now also. But it is going to be at least another year to 18 months till 2-73 as an AD treatment is approved. That means we would miss out on a whole year or more of AD sales.

I think they are trying to get the approvals for Rett and AD to happen very close together. That way we get a whole 7 years of AD sales all for Anavex.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News